MIR99AHG alleviates reflux esophagitis caused by gastroesophageal reflux disease by downregulating miR-200a-3p
Cytotechnology · 2026-06 · 78 (3)
DOI: 10.1007/s10616-026-00980-2 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cytotechnology, online erschienen am 02.05.2026. Verfasst von Jincai Chen und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastrointestinal Surgery, Affiliated Hospital of Jiangsu University, Zhenjiang, 212001 China. Die Arbeit nennt 33 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Reflux esophagitis (RE) can progress to severe complications if not diagnosed and treated promptly. MIR99AHG is downregulated in the precursor disease of RE. This study aims to investigate the expression and regulatory mechanisms of MIR99AHG in RE. This study included 176 patients with RE. RT-qPCR was used to detect the expression of MIR99AHG, miR-200a-3p, Bax, Bcl-2, and caspase-3 For cellular experiments: cell proliferation, apoptosis, and the levels of inflammatory cytokines in cell culture supernatants were assessed using CCK-8 assay, Annexin V-FITC/PI double staining, and ELISA, respectively. DLR validated the binding between MIR99AHG and miR-200a-3p. ROC analysis evaluated their diagnostic value. Pearson correlation analysis assessed their relationship. In the RE and cell model groups, MIR99AHG expression was downregulated while miR-200a-3p expression was upregulated. MIR99AHG targeted and bound miR-200a-3p, negatively regulating its expression. Both demonstrated significant diagnostic value. Following modeling with acid salts and bile salts, cellular proliferation capacity decreased, apoptosis rates increased, and inflammatory factor levels rose. Upon overexpression of MIR99AHG, miR-200a-3p expression levels were downregulated, leading to enhanced cellular proliferation capacity, reduced apoptosis rates, and decreased inflammatory factor levels. MIR99AHG represents a promising clinical biomarker in RE. By downregulating miR-200a-3p levels, MIR99AHG may promote proliferation and repair of esophageal mucosal epithelial cells, inhibit excessive apoptosis, and mitigate local inflammatory responses, thereby exerting multifaceted protective effects during RE progression.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Gastrointestinal Surgery, Affiliated Hospital of Jiangsu University, Zhenjiang, 212001 China.
- Jiamusi University, Jiamusi, 154007 China.
- Department of Gastroenterology, Jiaozhou Central Hospital of Qingdao, Qingdao, 266300 China.
- Clinical Nutrition Department, Jiaozhou Central Hospital of Qingdao, Qingdao, 266300 China.
- Endoscopy Center, Hangzhou Geriatric Hospital, 50 Jingxing Street, Gongshu District, Hangzhou, 310022 Zhejiang Province China.
Zitieren
APA
Chen, J., Liu, Q., Zheng, X., Wang, X., Wu, F., Li, C., & Tong, L. (2026). MIR99AHG alleviates reflux esophagitis caused by gastroesophageal reflux disease by downregulating miR-200a-3p. Cytotechnology, 78(3). https://doi.org/10.1007/s10616-026-00980-2
Vancouver
Chen J, Liu Q, Zheng X, Wang X, Wu F, Li C, et al. MIR99AHG alleviates reflux esophagitis caused by gastroesophageal reflux disease by downregulating miR-200a-3p. Cytotechnology. 2026;78(3). doi:10.1007/s10616-026-00980-2
BibTeX
@article{Chen2026,
author = {Chen, Jincai and Liu, Qianli and Zheng, Xiaowen and Wang, Xiaoxin and Wu, Fanyu and Li, Chunlei and Tong, Limin},
title = {MIR99AHG alleviates reflux esophagitis caused by gastroesophageal reflux disease by downregulating miR-200a-3p},
journal = {Cytotechnology},
year = {2026},
volume = {78},
number = {3},
doi = {10.1007/s10616-026-00980-2}
}
EUVIMED